Figure 5.

Treatment success according to patient-reported assessment at Week 1 and 4 with Cal/BD, Cal, and BD aerosol foam (full analysis set). Treatment success (by PaGA, considered body and scalp psoriasis together) was defined as “clear” or “very mild” disease. Missing values were imputed by LOCF for Week 4 comparisons; P-values were determined using Cochran–Mantel–Haenszel test, adjusting for pooled centers.

BD=betamethasone dipropionate 0.064%; Cal=calcipotriene 0.005%; LOCF=last Observation carried forward; PaGA=patient’s assessment of disease severity